S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
pixel
S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
pixel
S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
pixel
S&P 500   3,821.35
DOW   31,802.44
QQQ   299.94
pixel
Log in
NASDAQ:CDXC

ChromaDex News Headlines

$10.45
-0.28 (-2.61 %)
(As of 03/8/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.37
Now: $10.45
$12.23
50-Day Range
$4.67
MA: $7.34
$18.74
52-Week Range
$2.50
Now: $10.45
$23.66
Volume2.80 million shs
Average Volume4.48 million shs
Market Capitalization$645.68 million
P/E RatioN/A
Dividend YieldN/A
Beta1.49

Headlines

ChromaDex (NASDAQ CDXC) News Headlines Today

Source:
SourceHeadline
ChromaDex (NASDAQ:CDXC) Price Target Raised to $18.00ChromaDex (NASDAQ:CDXC) Price Target Raised to $18.00
americanbankingnews.com - March 9 at 4:28 AM
ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board - Business WireChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board - Business Wire
businesswire.com - March 8 at 8:12 PM
ChromaDex (CDXC) Surges 12%: Is This an Indication of Further Gains? - Yahoo FinanceChromaDex (CDXC) Surges 12%: Is This an Indication of Further Gains? - Yahoo Finance
finance.yahoo.com - March 8 at 10:10 AM
ChromaDex (CDXC) Surges 12%: Is This an Indication of Further Gains?ChromaDex (CDXC) Surges 12%: Is This an Indication of Further Gains?
finance.yahoo.com - March 8 at 10:10 AM
ChromaDex (NASDAQ:CDXC) Trading Up 12%ChromaDex (NASDAQ:CDXC) Trading Up 12%
americanbankingnews.com - March 5 at 6:42 PM
ChromaDex (NASDAQ:CDXC) Trading Down 16%ChromaDex (NASDAQ:CDXC) Trading Down 16%
americanbankingnews.com - March 4 at 9:35 PM
US$23.45 - Thats What Analysts Think ChampionX Corporation (NASDAQ:CHX) Is Worth After These Results - NasdaqUS$23.45 - That's What Analysts Think ChampionX Corporation (NASDAQ:CHX) Is Worth After These Results - Nasdaq
nasdaq.com - March 4 at 6:43 AM
ChromaDex (CDXC) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseChromaDex (CDXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - March 3 at 1:35 PM
ChromaDex (CDXC) Scheduled to Post Quarterly Earnings on WednesdayChromaDex (CDXC) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - March 3 at 2:02 AM
ChromaDex (NASDAQ:CDXC) Shares Gap Up to $13.93ChromaDex (NASDAQ:CDXC) Shares Gap Up to $13.93
americanbankingnews.com - March 1 at 9:47 AM
CDXC Stock: Why ChromaDex Shares Are Rocketing Higher Today - NasdaqCDXC Stock: Why ChromaDex Shares Are Rocketing Higher Today - Nasdaq
nasdaq.com - February 27 at 8:09 AM
Form SC 13G ChromaDex Corp. Filed by: Yong Rong (HK) Asset Management Ltd - StreetInsider.comForm SC 13G ChromaDex Corp. Filed by: Yong Rong (HK) Asset Management Ltd - StreetInsider.com
streetinsider.com - February 26 at 10:08 PM
ChromaDex (NASDAQ:CDXC)  Shares Down 25.7% ChromaDex (NASDAQ:CDXC) Shares Down 25.7%
americanbankingnews.com - February 26 at 8:32 PM
ChromaDex Sees Unusually Large Options Volume (NASDAQ:CDXC)ChromaDex Sees Unusually Large Options Volume (NASDAQ:CDXC)
americanbankingnews.com - February 25 at 1:02 PM
ChromaDex (NASDAQ:CDXC) Reaches New 12-Month High at $12.53ChromaDex (NASDAQ:CDXC) Reaches New 12-Month High at $12.53
americanbankingnews.com - February 25 at 11:16 AM
New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients - Business WireNew Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients - Business Wire
businesswire.com - February 24 at 2:09 PM
New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 PatientsNew Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients
finance.yahoo.com - February 24 at 9:08 AM
ChromaDex Co. (NASDAQ:CDXC) Expected to Post Earnings of -$0.11 Per ShareChromaDex Co. (NASDAQ:CDXC) Expected to Post Earnings of -$0.11 Per Share
americanbankingnews.com - February 24 at 2:12 AM
ChromaDex (NASDAQ:CDXC) Shares Up 15.6%ChromaDex (NASDAQ:CDXC) Shares Up 15.6%
americanbankingnews.com - February 22 at 7:01 PM
ChromaDex Announces $25 Million Private Placement of Common Stock - Business WireChromaDex Announces $25 Million Private Placement of Common Stock - Business Wire
businesswire.com - February 22 at 2:05 PM
Form 8-K ChromaDex Corp. For: Feb 20 - StreetInsider.comForm 8-K ChromaDex Corp. For: Feb 20 - StreetInsider.com
streetinsider.com - February 22 at 9:04 AM
ChromaDex raises $25M through private placement of common stock - Seeking AlphaChromaDex raises $25M through private placement of common stock - Seeking Alpha
seekingalpha.com - February 22 at 9:04 AM
ChromaDex Announces $25 Million Private Placement of Common StockChromaDex Announces $25 Million Private Placement of Common Stock
finance.yahoo.com - February 22 at 9:04 AM
Is ChromaDexs (NASDAQ:CDXC) Share Price Gain Of 110% Well Earned? - Yahoo FinanceIs ChromaDex's (NASDAQ:CDXC) Share Price Gain Of 110% Well Earned? - Yahoo Finance
finance.yahoo.com - February 20 at 8:54 AM
ChromaDex to Report Fourth Quarter 2020 Financial Results on Wednesday, March 10, 2021 - Yahoo FinanceChromaDex to Report Fourth Quarter 2020 Financial Results on Wednesday, March 10, 2021 - Yahoo Finance
finance.yahoo.com - February 20 at 8:54 AM
Is ChromaDexs (NASDAQ:CDXC) Share Price Gain Of 110% Well Earned?Is ChromaDex's (NASDAQ:CDXC) Share Price Gain Of 110% Well Earned?
finance.yahoo.com - February 20 at 8:54 AM
ChromaDex (NASDAQ:CDXC) Hits New 52-Week High at $8.60ChromaDex (NASDAQ:CDXC) Hits New 52-Week High at $8.60
americanbankingnews.com - February 19 at 9:02 PM
ChromaDex (NASDAQ:CDXC) Shares Up 17.9%ChromaDex (NASDAQ:CDXC) Shares Up 17.9%
americanbankingnews.com - February 16 at 7:18 PM
This Bioscience Company Is Trying To Defy The Aging ProcessThis Bioscience Company Is Trying To Defy The Aging Process
finance.yahoo.com - February 12 at 5:54 PM
CDXC Feb 2021 2.500 callCDXC Feb 2021 2.500 call
uk.finance.yahoo.com - February 11 at 3:02 PM
Thorne Research, Inc., Continues to Challenge the Validity of US Patents on Nicotinamide Riboside - PRNewswireThorne Research, Inc., Continues to Challenge the Validity of US Patents on Nicotinamide Riboside - PRNewswire
prnewswire.com - February 4 at 9:29 AM
New Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver Function - Business WireNew Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver Function - Business Wire
businesswire.com - February 4 at 9:29 AM
New Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver FunctionNew Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver Function
finance.yahoo.com - February 4 at 9:29 AM
What You Need To Know About ChromaDex Corporations (NASDAQ:CDXC) Investor Composition - Yahoo FinanceWhat You Need To Know About ChromaDex Corporation's (NASDAQ:CDXC) Investor Composition - Yahoo Finance
finance.yahoo.com - December 22 at 7:17 AM
What You Need To Know About ChromaDex Corporations (NASDAQ:CDXC) Investor CompositionWhat You Need To Know About ChromaDex Corporation's (NASDAQ:CDXC) Investor Composition
finance.yahoo.com - December 22 at 7:17 AM
ChromaDex Corp.ChromaDex Corp.
barrons.com - December 20 at 10:44 PM
ChromaDex (CDXC) in Focus: Stock Moves 5.6% Higher - Yahoo FinanceChromaDex (CDXC) in Focus: Stock Moves 5.6% Higher - Yahoo Finance
finance.yahoo.com - December 14 at 9:36 AM
ChromaDex (CDXC) in Focus: Stock Moves 5.6% HigherChromaDex (CDXC) in Focus: Stock Moves 5.6% Higher
finance.yahoo.com - December 14 at 9:36 AM
ChromaDex to Present at Benzingas Inaugural Small Cap Conference in December 2020 - Business WireChromaDex to Present at Benzinga's Inaugural Small Cap Conference in December 2020 - Business Wire
businesswire.com - December 2 at 4:58 PM
Is ChromaDex (CDXC) A Good Stock To Buy Now?Is ChromaDex (CDXC) A Good Stock To Buy Now?
finance.yahoo.com - December 2 at 4:58 PM
ChromaDex to Present at Benzinga’s Inaugural Small Cap Conference in December 2020ChromaDex to Present at Benzinga’s Inaugural Small Cap Conference in December 2020
finance.yahoo.com - December 2 at 8:15 AM
ChromaDex initiates human clinical trial of Niagen to increase milk production among preterm mothersChromaDex initiates human clinical trial of Niagen to increase milk production among preterm mothers
seekingalpha.com - November 17 at 12:39 PM
ChromaDex Announces New Clinical Trial to Investigate Niagen® and Milk Production Among Mothers in the Neonatal Intensive Care Unit (NICU)ChromaDex Announces New Clinical Trial to Investigate Niagen® and Milk Production Among Mothers in the Neonatal Intensive Care Unit (NICU)
finance.yahoo.com - November 17 at 7:38 AM
ChromaDex and Watsons Launch New TRU NIAGEN® EX Stick Packs in Hong Kong, Expanding Product Line and Advancing Global Retail Partnership - Business WireChromaDex and Watsons Launch New TRU NIAGEN® EX Stick Packs in Hong Kong, Expanding Product Line and Advancing Global Retail Partnership - Business Wire
businesswire.com - November 9 at 3:05 PM
ChromaDex and Watsons Launch New TRU NIAGEN® EX Stick Packs in Hong Kong, Expanding Product Line and Advancing Global Retail PartnershipChromaDex and Watsons Launch New TRU NIAGEN® EX Stick Packs in Hong Kong, Expanding Product Line and Advancing Global Retail Partnership
finance.yahoo.com - November 9 at 10:04 AM
Chromadex: The Little Company That Could - Seeking AlphaChromadex: The Little Company That Could - Seeking Alpha
seekingalpha.com - November 8 at 8:08 AM
Earnings Update: Heres Why Analysts Just Lifted Their ChromaDex Corporation (NASDAQ:CDXC) Price Target To US$8.00 - Yahoo FinanceEarnings Update: Here's Why Analysts Just Lifted Their ChromaDex Corporation (NASDAQ:CDXC) Price Target To US$8.00 - Yahoo Finance
finance.yahoo.com - November 7 at 2:18 PM
Earnings Update: Heres Why Analysts Just Lifted Their ChromaDex Corporation (NASDAQ:CDXC) Price Target To US$8.00Earnings Update: Here's Why Analysts Just Lifted Their ChromaDex Corporation (NASDAQ:CDXC) Price Target To US$8.00
finance.yahoo.com - November 7 at 2:18 PM
Have Insiders Been Buying ChromaDex Corporation (NASDAQ:CDXC) Shares?Have Insiders Been Buying ChromaDex Corporation (NASDAQ:CDXC) Shares?
finance.yahoo.com - November 7 at 2:18 PM
ChromaDexs (CDXC) CEO Rob Fried on Q3 2020 Results - Earnings Call TranscriptChromaDex's (CDXC) CEO Rob Fried on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 7:40 AM
This page was last updated on 3/9/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.